A drug which is said to "reboot" the immune system has been shown to be an effective treatment for multiple sclerosis (MS), a study has found.
The results of the trials were so encouraging in reducing the number of attacks in those affected that the MS Society is campaigning for the drug to become available on the NHS.
The research showed that alemtuzumab significantly reduced the number of attacks or relapses by people with MS compared to the current drug interferon beta-1a which is known commercially as Rebif.
More top news
Private schools have offered to create 10,000 free places for poorer students but only if the government helps fund them.
The mother of a missing RAF serviceman has hired a private investigator to help search for her son after raising thousands of pounds.
Dozens of potential suspects have been identified in connection with historical child sexual abuse allegations in football, police say.